Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Jun;30(6):810-6.
doi: 10.1007/s11606-015-3214-9. Epub 2015 Feb 10.

A Randomized Controlled Effectiveness Trial for PSA Screening Decision Support Interventions in Two Primary Care Settings

Affiliations
Randomized Controlled Trial

A Randomized Controlled Effectiveness Trial for PSA Screening Decision Support Interventions in Two Primary Care Settings

Carmen L Lewis et al. J Gen Intern Med. 2015 Jun.

Abstract

Background: Decision support interventions (DESIs) provide a mechanism to translate comparative effectiveness research results into clinical care so that patients are able to make informed decisions. Patient decision support interventions for prostate-specific antigen (PSA) have been shown to promote informed decision making and reduce PSA testing in efficacy trials, but their impact in real world settings is not clear.

Objective: We performed an effectiveness trial of PSA decision support interventions in primary care.

Design: A randomized controlled trial of three distribution strategies was compared to a control.

Participants: Participants included 2,550 men eligible for PSA testing (76.6 % of the eligible population) and 2001 survey respondents (60.1 % survey response rate).

Interventions: The intervention groups were: 1) mailed the DESI in DVD format, 2) offered a shared medical appointment (SMA) to view the DESI with other men and discuss, and 3) both options.

Main measures: We measured PSA testing identified via electronic medical record at 12 months and DESI use by self-report 4 months after the intervention mailing.

Key results: We found no differences in PSA testing across the three distribution strategies over a year-long follow-up period: 21 %, 24 %, 22 % in the DESI, SMA, and combined group respectively, compared to 21 % in the control group (p = 0.51). Self-reported DESI use was low across all strategies at 4 months: 16 % in the mailed DESI group, 6 % in the SMA group, and 15 % in the combined group (p = < 0.0001).

Conclusions: Mailing PSA decision support interventions or inviting men to shared medical appointments unrelated to a primary care office visit do not appear to promote informed decision making, or change PSA testing behavior.

Trial registration: ClinicalTrials.gov NCT01241656.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Randomization, eligibility, and participation

Comment in

References

    1. Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2011;10 - PubMed
    1. Centers for Disease Control and Prevention. http://www.cdc.gov/cancer/prostate/basic_info/screening.htm. Accessed Jan 23 2015.
    1. National Cancer Institute FactSheet: Prostate-Specific Antigen (PSA) Test. National Cancer Instititute. 2012. http://www.cancer.gov/cancertopics/factsheet/detection/PSA. Accessed Jan 23 2015.
    1. American Cancer Society recommendations for prostate cancer early detection. American Cancer Society. 2012. http://www.cancer.org/cancer/prostatecancer/moreinformation/prostatecanc.... Accessed Jan 23 2015.
    1. Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, et al. Early Detection of Prostate Cancer: AUA Guideline. J Urol. 2013;190(2):419–26. doi: 10.1016/j.juro.2013.04.119. - DOI - PMC - PubMed

Publication types

Associated data